Literature DB >> 15855628

Differential expression of the PEA3 subfamily of ETS transcription factors in the mouse ovary and peri-implantation uterus.

Tae Bon Koo1, Haengseok Song, Irene Moon, Kyuyong Han, Chen Chen, Kenneth Murphy, Hyunjung Lim.   

Abstract

The objective of the present investigation was to examine the spatio-temporal expression of three members of the ETS family of transcription factors, ERM, ER81, and PEA3, in the peri-implantation mouse uterus and in the ovary. These three factors belong to the PEA3 subfamily and are known to mediate diverse functions ranging from neuronal development to tumor progression. As transcription factors, they regulate the expression of a number of genes with various biological functions. Since several genes with known roles in the reproductive processes have been shown to be under the regulation of one of these factors, we sought to investigate the expression of ERM, ER81, and PEA3 in the mouse ovary and uterus. Quantitative RT-PCR analyses showed that ERM, ER81, and PEA3 were all expressed in the peri-implantation mouse uterus, with higher levels of expression on days 4 and 5 of pregnancy. To determine the cell type-specific expression of these factors, we employed in situ hybridization, the results of which revealed that ERM was expressed in both the epithelium and the stroma on days 4 and 5 of pregnancy. Uterine glands showed a high expression of ERM on those days. ERM was also highly expressed in the corpora lutea of the mouse ovary. Both ER81 and PEA3 were expressed at low levels in the stroma on days 4 and 5. On day 8, while ERM and PEA3 were mainly expressed in the embryo and were at low levels in the maternal decidua in a diffused pattern, ER81 was highly expressed in the vascular bed of the mesometrial deciduum. Both ER81 and PEA3 were undetectable in the mouse ovary. Collectively, these data show that ERM is implicated in the early event of implantation as well as in ovarian functions, while ER81 is involved in the establishment of the maternal vasculature for subsequent placental development. PEA3 is apparently an embryonic factor for early embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855628     DOI: 10.1530/rep.1.00656

Source DB:  PubMed          Journal:  Reproduction        ISSN: 1470-1626            Impact factor:   3.906


  6 in total

1.  Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

Authors:  María Abad; Lluc Mosteiro; Cristina Pantoja; Marta Cañamero; Teresa Rayon; Inmaculada Ors; Osvaldo Graña; Diego Megías; Orlando Domínguez; Dolores Martínez; Miguel Manzanares; Sagrario Ortega; Manuel Serrano
Journal:  Nature       Date:  2013-09-11       Impact factor: 49.962

2.  PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.

Authors:  Karen D Cowden Dahl; Reema Zeineldin; Laurie G Hudson
Journal:  Mol Cancer Res       Date:  2007-05-02       Impact factor: 5.852

3.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 4.  EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma.

Authors:  Laurie G Hudson; Natalie M Moss; M Sharon Stack
Journal:  Future Oncol       Date:  2009-04       Impact factor: 3.404

5.  Differential expression of the metastasis suppressor KAI1 in decidual cells and trophoblast giant cells at the feto-maternal interface.

Authors:  Tae Bon Koo; Min-Su Han; Yamashita Tadashi; Won Joon Seong; Je-Yong Choi
Journal:  BMB Rep       Date:  2013-10       Impact factor: 4.778

6.  C-kit signaling promotes human pre-implantation 3PN embryonic development and blastocyst formation.

Authors:  Jun Tan; Yang Zou; Zhi-Hui Huang; Zhi-Qin Zhang; Li-Ping Wu; Xing-Wu Wu; Xiao-Ju Wan; Cai-Lin Xin; Qiong-Fang Wu
Journal:  Reprod Biol Endocrinol       Date:  2019-09-10       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.